LEK S.A.,Poland
| Държава: | Полша |
| Кратка информация: | Lek SA is a manufacturing company, a subsidiary of Sandoz. Lek SA Management Board consists of: Cristian Neculicioiu - Chairman of the Board, Paulina Pazio - Board member, Alan Knox - Board member, Rafal Gardener - a member of the Board. Office and office; Street. Podlipie 16, 95 - 010 Stryków. KRS: 0000061723, District Court for Lodz City Centre, XX Fac. KRS. NIP: 728-134-19-36. Share capital: 11 409 350 zł - paid in full. http://www.sandoz.pl/site/pl/o_nas/nasze_wartosci/index.shtml Sandoz in Poland Under the name Sandoz company operates in Poland since January 2010, continuing the tradition of the brand drug Poland and Hexal. Sandoz in Poland is one of the leading generics. These drugs affect the greater availability, and hence the effectiveness of therapy. Their affordable price and high quality determine the possibilities of wider use of effective therapies, while providing significant savings for both patients and the state budget. Lek SA Company under the Sandoz Group in Poland, specializes in the manufacture and distribution of generic drugs, whose production requires advanced technologies. Group offers 140 active substances contained in the 455 medicinal products. The main treatment groups: Cardiovascular Drugs Antibiotics Analgesics Drugs & Low Antiasthmatic and antiallergic drugs Oncology drugs Neurological and Psychiatric Medications Group offers a variety of drugs available for sale freehand (without prescription). Main brands: It Ketonal ACC Linex Persen Deprim Sandoz supports efforts to improve early detection of diseases such as anemia, hypertension, lipid disorders, and chronic obstructive pulmonary disease. Preventive actions of the Group included its reach thousands of patients and allowed to help patients suffering from diseases of civilization. Sandoz, upholding the traditions of the brand drug and Hexal, is currently on the Polish market in the second position among the generic companies. For several years the company has steadily increased sales. In the year 2009 exceeded 750 million zł (source IMS Health data) |
| Сайт: | http://www.sandoz.pl/site/pl/o_nas/lek_sa/index.shtml |
